Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma

Conditions: Osteosarcoma; Soft Tissue Sarcoma Interventions: Drug: NK510; Drug: NK510 Sponsors: Base Therapeutics (Shanghai) Co., Ltd.; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials